| Target | cis/trans | Study | SNP | SNP location | Maj/min allele | MAF | N | βinv | seinv | Pinv | fclog | Plog | Praw |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| bFGF | cis | Discovery | rs308403 | 4:123,757,748 | C/T | 0.32 | 996 | -0.590 | 0.043 | 5.8×10-39 | -1.340 | 2.4×10-16 | 0.029 |
| bFGF | cis | Replication | rs308403 | 4:123,757,748 | G/A | 0.47 | 337 | -0.386 | 0.068 | 3.7×10-8 | -1.280 | 0.001 | 0.994 |
| Target (abbrv.) | bFGF |
| Target (full name) | Fibroblast growth factor 2 |
| Somalogic ID (Sequence ID) | SL000004 (3025-50_1) |
| Entrez Gene Symbol | FGF2 |
| UniProt ID | P09038 |
| UniProt Comment |
|
| Targeted by drugs (based on IPA annotation) |
|
| Biomarker applications (based on IPA annotation) |
|
| Wiki Pathways |
|
| Pathway Interaction Database |
|
| Reactome |
|
| Pathway Studio |
|
All locus annotations are based on the sentinel SNP (rs308403) and 1 proxy variant(s) that is/are in linkage disequilibrium r2 ≥ 0.8. Linkage disequilibrium is based on data from the 1000 Genomes Project, phase 3 version 5, European population and was retrieved using SNiPA's Block Annotation feature.
Download the detailed results of SNiPA's block annotation (PDF)
| Genes hit or close-by |
|